SCHEMBL19081952

SCHEMBL19081952

c1cc(-c2ccc3c(c2)sc2c3ccc3oc4c5ccccc5ccc4c32)cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 1/20 0.34
LIMK2 P53671 1/20 0.34
CYP1A1 P04798 12/20 0.33
CYP1B1 Q16678 12/20 0.33
CYP1A2 P05177 11/20 0.33
PRKDC P78527 3/20 0.33
KDM4E B2RXH2 1/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
CYP2B6 P20813 1/20 0.33
TACR2 P21452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081845 0.92 CYP1A1 (0.40) LIMK1LIMK2CYP1A1CYP1B1CYP1A2
SCHEMBL19081953 0.88 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19081923 0.88 ALOX5 (0.33) LIMK1CYP1A1CYP1B1CYP1A2PRKDC
SCHEMBL24341337 0.88 ALOX5 (0.39) LIMK1LIMK2CYP1A1CYP1B1CYP1A2
SCHEMBL19081785 0.86 ALOX5 (0.36) LIMK1CYP1A1CYP1A2PRKDCALDH1A1
SCHEMBL19076705 0.86 ALOX5 (0.37) PRKDCALOX5
SCHEMBL17944150 0.85 ALOX5 (0.35) CYP1A1CYP1B1CYP1A2PRKDCKDM4E
SCHEMBL19109299 0.85 ALOX5 (0.41) LIMK1LIMK2CYP1A1CYP1B1CYP1A2
SCHEMBL19082258 0.85 CYP1A1 (0.40) LIMK1LIMK2CYP1A1CYP1B1CYP1A2
SCHEMBL17247210 0.85 CYP1A1 (0.43) LIMK1LIMK2CYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 LIMK1 440/4885LIMK2 1292/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 LIMK1 440/4885LIMK2 1292/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.